Article
CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response.
Alzheimer's research & therapy - 9 Nov 2023
Duchateau Lena, Küҫükali Fahri, De Roeck Arne, Wittens Mandy M J, Temmerman Joke, Weets Ilse, Timmers Maarten, Engelborghs Sebastiaan, Bjerke Maria, Sleegers Kristel
Abstract excerpt
BACKGROUND: The Alzheimer's disease (AD) risk gene ABCA7 has suggested functions in lipid metabolism and the immune system. Rare premature termination codon (PTC) mutations and an expansion of a variable number of tandem repeats (VNTR) polymorphism in the gene, both likely cause a lower ABCA7 expression and hereby increased risk for AD. However, the exact mechanism of action remains unclear. By studying CSF...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
